Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences

Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences

Bibliographic Details
Main Authors:	Shalakha Hegde, Zhichao Tang, Junxing Zhao, Jingxin Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Chemistry
Subjects:	SARS-CoV-2 antiviral RNA-targeting small molecule antisense oligonucleotide untranslated region
Online Access:	https://www.frontiersin.org/articles/10.3389/fchem.2022.842171/full

Similar Items

Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences
by: Shalakha Hegde, et al.
Published: (2021-12-01)

RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
by: Zhichao Tang, et al.
Published: (2021-04-01)

DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
by: Volodymyr V. Oberemok, et al.
Published: (2023-01-01)

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics
by: Benjamin Ayodipupo Babalola, et al.
Published: (2023-09-01)

Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication
by: Kingshuk Panda, et al.
Published: (2021-02-01)

Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules
by: Manuel Hawner, et al.
Published: (2020-12-01)

Medicinal Chemistry of Oligonucleotide Drugs - Milestones of the Past and Visions for the Future
by: Jonathan Hall, et al.
Published: (2022-05-01)

Quantitative fluorescence imaging of antisense oligonucleotide mediated knockdown
by: Chan, Nicholas Zhen Woon
Published: (2024)

A perspective on oligonucleotide therapy: Approaches to patient customization
by: Shikha Thakur, et al.
Published: (2022-10-01)

Application of RNAi in Biomedical Research
by: Jonathan Hall
Published: (2005-11-01)

Antisense oligonucleotides targeting ORF1b block replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
by: Sophie Dhorne-Pollet, et al.
Published: (2022-10-01)

The Use of Antisense Oligonucleotides in Evaluating Survivin as a Therapeutic Target for Radiation Sensitization in Lung Cancer
by: Shinohara Eric T., et al.
Published: (2004-01-01)

Inhibitory Effect of Nano-oligonucleotides as a New Nanotechnology Method in Gene Therapy of Leukemia In Vitro
by: Rabbani M, et al.
Published: (2011-06-01)

Refining the concept of GFAP toxicity in Alexander disease
by: Albee Messing
Published: (2019-12-01)

Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
by: Ilaria Andreana, et al.
Published: (2021-02-01)

Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication
by: Ekaterina Knizhnik, et al.
Published: (2023-11-01)

Antisense Therapy for Infectious Diseases
by: Lwanda Abonga Buthelezi, et al.
Published: (2023-08-01)

Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies
by: Carme Fàbrega, et al.
Published: (2023-01-01)

Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery
by: Rudolph L. Juliano
Published: (2021-05-01)

HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness
by: Jessica SY Ho, et al.
Published: (2021-06-01)

Oligonucleotide Technology – A Research Platform for Chemical Biology
by: Robert Häner
Published: (2001-04-01)

Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice
by: Rosie Z Yu, et al.
Published: (2016-01-01)

History of Research on Antisense Oligonucleotide Analogs
by: Jack S. Cohen
Published: (2021-03-01)

Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
by: Jun Chen, et al.
Published: (2000-05-01)

THERAPEUTIC ANTISENSE OLIGONUCLEOTIDES AGAINST CANCER: HURDLING TO THE CLINIC
by: Pedro Miguel Duarte Moreno, et al.
Published: (2014-10-01)

Potential Of Antisense Oligonucleotides (ASO) Through Inhalation Based On Gold Nanoparticle (AuNP) Delivery System In Inhibiting SARS-CoV-2 Replication And Transcription
by: Raehan Satya Deanasa, et al.
Published: (2022-09-01)

NanoSIMS Imaging Reveals the Impact of Ligand-ASO Conjugate Stability on ASO Subcellular Distribution
by: Emma Kay, et al.
Published: (2022-02-01)

Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
by: Oleg V. Markov, et al.
Published: (2020-08-01)

LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
by: O. I. Afanasieva, et al.
Published: (2015-09-01)

Duchenne Muscular Dystrophy: From Diagnosis to Therapy
by: Maria Sofia Falzarano, et al.
Published: (2015-10-01)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by: Wu Zhong, et al.
Published: (2022-11-01)

Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
by: Chisato Terada, et al.
Published: (2022-11-01)

An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the <i>MSTN</i> Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin Inhibitor
by: Kazuhiro Maeta, et al.
Published: (2022-04-01)

RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication
by: Marta Szabat, et al.
Published: (2020-11-01)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Changes induced in mouse lipid metabolism by simultaneous impact of antisense oligonucleotide derivatives to <i>apoB</i>, <i>PCSK9</i>, and <i>apoCIII</i> mRNAs
by: S. I. Oshevski, et al.
Published: (2020-01-01)

Rheumatoid Arthritis Has Won the Battle but Not the War: How Many Joints Will We Save Tomorrow?
by: Volodymyr V. Oberemok, et al.
Published: (2023-10-01)

Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material
by: Hiroki Tanaka, et al.
Published: (2021-04-01)

Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
by: Guillaume Sicard, et al.
Published: (2020-11-01)

Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
by: Valentina Giudice, et al.
Published: (2020-05-01)